v3.26.1
Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jul. 05, 2026
Jun. 29, 2025
Jul. 05, 2026
Jun. 29, 2025
Dec. 28, 2025
Disaggregation of Revenue [Line Items]          
Segment revenue $ 729,688 $ 720,284 $ 1,440,806 $ 1,385,046  
Unbilled Receivables 100,400   100,400   $ 105,600
Unbilled Receivables, Current 68,200   68,200   72,400
Unbilled Receivables, noncurrent 32,200   32,200   33,200
Deferred Revenue 239,800   239,800   224,800
Deferred Revenue, Current 174,300   174,300   159,300
Deferred Revenue, Noncurrent 65,500   65,500   65,500
Customer Deposits Received in Advance of Transfer of Control $ 16,000   $ 16,000   $ 19,300
Remaining Performance Obligations     Transaction price allocated to the remaining performance obligationsThe Company applies the practical expedient and does not disclose information about remaining performance obligations that have original expected durations of one year or less. The estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at the end of the period are not material to the Company. The remaining performance obligations primarily include noncancelable purchase orders, noncancelable software subscriptions and cloud service contracts and long-term prepaid storage contracts.    
Contract with Customer, Asset and Liability [Abstract]          
Contract with Customer, Asset, Net, Current - Not Material The Company had no material contract assets as of July 5, 2026 and December 28, 2025.        
Americas [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue $ 325,583 323,580 $ 641,575 628,209  
Europe [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue 229,041 203,632 452,087 385,424  
Asia [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue 175,064 193,072 347,144 371,413  
Diagnostics [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue 370,989 354,386 720,262 678,753  
Diagnostics [Member] | Americas [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue 142,008 126,509 272,449 246,859  
Diagnostics [Member] | Europe [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue 139,563 119,334 270,914 225,104  
Diagnostics [Member] | Asia [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue 89,418 108,543 176,899 206,790  
Life Sciences [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue 358,699 365,898 720,544 706,293  
Life Sciences [Member] | Americas [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue 183,575 197,071 369,126 381,350  
Life Sciences [Member] | Europe [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue 89,478 84,298 181,173 160,320  
Life Sciences [Member] | Asia [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue 85,646 84,529 170,245 164,623  
Life Sciences Solutions [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue 301,028 298,052 601,024 584,505  
Life Sciences Solutions [Member] | Diagnostics [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue 0 0 0 0  
Life Sciences Solutions [Member] | Life Sciences [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue 301,028 298,052 601,024 584,505  
Software [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue 57,671 67,846 119,520 121,788  
Software [Member] | Diagnostics [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue 0 0 0 0  
Software [Member] | Life Sciences [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue 57,671 67,846 119,520 121,788  
Reproductive health [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue 156,231 135,568 303,673 262,373  
Reproductive health [Member] | Diagnostics [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue 156,231 135,568 303,673 262,373  
Reproductive health [Member] | Life Sciences [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue 0 0 0 0  
Applied genomics [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue   720,284   1,385,046  
Immunodiagnostics [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue 214,758 218,818 416,589 416,380  
Immunodiagnostics [Member] | Diagnostics [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue 214,758 218,818 416,589 416,380  
Immunodiagnostics [Member] | Life Sciences [Member]          
Disaggregation of Revenue [Line Items]          
Segment revenue $ 0 $ 0 $ 0 $ 0